Moleculin Biotech, Inc.
MBRX
$2.34
-$0.10-4.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.12M | 8.87M | 8.90M | 8.87M | 8.79M |
| Depreciation & Amortization | 90.00K | 112.00K | 122.00K | 125.00K | 126.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.10M | 24.21M | 25.44M | 25.91M | 26.64M |
| Operating Income | -25.10M | -24.21M | -25.44M | -25.91M | -26.64M |
| Income Before Tax | -33.56M | -55.70M | -37.32M | -27.51M | -26.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.56 | -55.70 | -37.32 | -27.51 | -26.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.56M | -55.70M | -37.32M | -27.51M | -26.05M |
| EBIT | -25.10M | -24.21M | -25.44M | -25.91M | -26.64M |
| EBITDA | -25.01M | -24.10M | -25.32M | -25.78M | -26.52M |
| EPS Basic | -54.62 | -94.18 | -124.44 | -170.33 | -203.50 |
| Normalized Basic EPS | -34.11 | -58.86 | -77.77 | -106.46 | -127.18 |
| EPS Diluted | -54.62 | -94.18 | -124.44 | -170.33 | -203.50 |
| Normalized Diluted EPS | -34.11 | -58.86 | -77.77 | -106.46 | -127.18 |
| Average Basic Shares Outstanding | 4.74M | 2.70M | 1.36M | 826.10K | 550.90K |
| Average Diluted Shares Outstanding | 4.74M | 2.70M | 1.36M | 826.10K | 550.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |